An Analysis of Antibacterial Drug Development Trends in the United States, 1980-2019.

Dheman, Nidhi; Mahoney, Nicole; Cox, Edward M; Farley, John J; Amini, Thushi; Lanthier, Michael L

Dheman, Nidhi; Mahoney, Nicole; Cox, Edward M; Farley, John J; Amini, Thushi; Lanthier, Michael L.

Afiliación

Dheman N; Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Mahoney N; Flatiron Health, Washington, District of Columbia, USA.
Cox EM; Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Farley JJ; Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Amini T; Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Lanthier ML; Economics Staff, Office of Economics and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, Maryland, USA.

Clin Infect Dis ; 73(11): e4444-e4450, 2021 12 06.

Article en En | MEDLINE | ID: mdl-32584952

Asunto(s)

Antibacterianos; Drogas en Investigación; Antibacterianos/farmacología; Antibacterianos/uso terapéutico; Aprobación de Drogas; Desarrollo de Medicamentos; Humanos; Estados Unidos; United States Food and Drug Administration

Palabras clave

antibacterial drugs; drug development

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Drogas en Investigación / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google